Predictive testing of early CIN behaviour by molecular biomarkers

Cellular Oncology

Volumn 27, Issue 5-6, 2005, Pages 277-280

  Baak, Jan P A ^a,b,c   Kruse, Arnold Jan ^a   Janssen, Emiel ^a   Van Diermen, Bianca ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; KI 67 ANTIGEN;

CANCER RISK; DIAGNOSTIC TEST; EDITORIAL; HUMAN; MOLECULAR DYNAMICS; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA IN SITU; VALIDATION PROCESS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; FEMALE; HUMANS; KI-67 ANTIGEN; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 29244469473     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. D. Amadori, O. Nanni, M. Marangolo, P. Pacini, A. Ravaioli, A. Rossi, A. Gambi, G. Catalano, D. Perroni, E. Scarpi, D.C. Giunchi, A. Tienghi, A. Becciolini and A. Volpi, Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter study, J. Clin. Oncol. 18 (2000), 3125-3134.
2. J.P. Baak, The framework of pathology: good laboratory practice by quantitative and molecular methods, J. Pathol. 198(3) (2002), 277-283.
3. J.P. Baak, P.J. van Diest, F.J. Voorhorst, E. van der Wall, L.V. Beex, J.B. Vermerken and E.A. Janssen, Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years, J. Clin. Oncol. 23(25) (2005), 5993-6001.
4. P.A. Hall and J.J. Going, Predicting the future: a critical appraisal of cancer prognosis studies, Histopathology 35(6) (1999), 489-494.
5. A.J. Kruse, J.P. Baak, T. Helliesen, K.H. Kjellevold, M.G. Bol and E.A. Janssen, Evaluation of MIB-1-positive cell clusters as a diagnostic marker for cervical intraepithelial neoplasia, Am. J. Surg. Pathol. 26(11) (2002), 1501-1507.
6. A.J. Kruse, J.P. Baak, E.A. Janssen, M.G. Bol, K.H. Kjellevold, B. Fianne, K. Lovslett and J. Bergh, Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immuno-quantitative variables, J. Pathol. 199(4) (2003), 462-170.
7. A.J. Kruse, J.P. Baak, E.A. Janssen, K.H. Kjellevold, B. Fiane, K. Lovslett, J. Bergh and S. Robboy, Ki67 predicts progression in early CIN: validation of a multivariate progression-risk model, Cell. Oncol. 26(1-2) (2004), 13-20.
8. A.J. Kruse, E. Gudlaugsson, T. Helliesen, E.A. Janssen, B. van Diermen, S. Sandvik and J.P. Baak, Evaluation of prospective, routine application of Ki-67 immunoquantitation in early CIN for assessment of short-term progression risk, Anal. Quant. Cytol. Histol. 26(3) (2004), 134-140.
9. A.J. Kruse, I. Skaland, E.A. Janssen, S. Buhr-Wildhagen, J. Klos, M.J. Arends and J.P. Baak, Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability, Int. J. Gynecol. Pathol. 23(2) (2004), 100-109.
10. A.G. Ostor, Natural history of cervical intraepithelial neoplasia: a critical review, Int. J. Gynecol. Pathol. 12(2) (1993), 186-192.
11. E.C. Pirog, R.N. Baergen, R.A. Soslow, D. Tam, A.E. DeMattia, Y.T. Chen and C. Isacson, Diagnostic accuracy of cervical low-grade squamous intraepithelial lesions is improved with MIB-1 immunostaining, Am. J. Surg. Pathol. 26(1) (2002), 70-75.
12. R. Silvestrini, Letter to the editor: Ki67 predicts progression in early CIN: Validation of a multivariate progression-risk model, Cell. Oncol. (2005), 355.
13. R. Silvestrini, M.G. Daidone, A. Luisi, M. Mastore, M. Leutner and B. Salvadori, Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index, Int. J. Cancer 74 (1997), 122-127.